{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:13:30Z","timestamp":1785888810447,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.humpath.2009.01.003","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T08:15:23Z","timestamp":1239783323000},"page":"1176-1181","source":"Crossref","is-referenced-by-count":15,"title":["Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray"],"prefix":"10.1016","volume":"40","author":[{"given":"Daron J.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta Van","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary M.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2009.01.003_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumors","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2009.01.003_bib2","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2009.01.003_bib3","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18 Suppl","key":"10.1016\/j.humpath.2009.01.003_bib4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1200\/jco.2006.24.18_suppl.508","article-title":"Prevalence of BRCA1 mutations in triple negative breast cancer (BC)","volume":"24","author":"Kandel","year":"2006","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"10.1016\/j.humpath.2009.01.003_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1470-2045(07)70074-8","article-title":"Triple-negative breast cancer: therapeutic options","volume":"8","author":"Cleator","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2009.01.003_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.breast.2006.09.003","article-title":"The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies","volume":"16","author":"Siziopikou","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.humpath.2009.01.003_bib7","series-title":"SEER Cancer statistics review, 1975-2000","author":"Ries","year":"2003"},{"key":"10.1016\/j.humpath.2009.01.003_bib8","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)\u2013negative, progesterone receptor (PR)\u2013negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2009.01.003_bib9","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1093\/jjco\/hye127","article-title":"The situation with cancer control in Vietnam","volume":"32","author":"Anh","year":"2002","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.humpath.2009.01.003_bib10","first-page":"601","article-title":"Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older","volume":"11","author":"Li","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2009.01.003_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/bjc.1997.540","article-title":"Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma","volume":"76","author":"Toikkanen","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2009.01.003_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00129039-200406000-00007","article-title":"Rates of estrogen receptor-\u03b1 expression are no different in low-risk (Vietnam) and high-risk (Australian) breast cancer","volume":"12","author":"Tran","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2009.01.003_bib13","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2009.01.003_bib14","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1158\/1078-0432.CCR-04-2064","article-title":"Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer","volume":"11","author":"Arnes","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2009.01.003_bib15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00428-005-0010-7","article-title":"p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas","volume":"447","author":"Matos","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2009.01.003_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-006-9301-1","article-title":"Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature","volume":"101","author":"Luini","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2009.01.003_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-7-134","article-title":"Use of immunohistochemical markers can refine prognosis in triple negative breast cancer","volume":"7","author":"Tischkowitz","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2009.01.003_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2009.01.003_bib19","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1158\/1078-0432.CCR-03-0114","article-title":"Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer","volume":"10","author":"Woelfle","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2009.01.003_bib20","first-page":"1101","article-title":"Immunohistochemical analysis of cytokeratin #8 as a prognostic factor in invasive breast carcinoma","volume":"15","author":"Takei","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2009.01.003_bib21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/path.1559","article-title":"Expression of luminal and basal cytokeratins in human breast carcinoma","volume":"203","author":"El-Rehim","year":"2004","journal-title":"J Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817709000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817709000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:19:55Z","timestamp":1589721595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817709000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0046817709000100"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2009.01.003","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}